HIV Researchers Slam The Scientist Who Made Genetically Engineered Babies
By Nidhi Subbaraman,
BuzzFeed
| 11. 26. 2018
“I’m angry on behalf of the genetic engineering community. I’m angry on behalf of the HIV community,” one expert said. The researchers said that existing methods already offer parents simple ways to have children without transmitting the disease.
HIV researchers are incensed that the first reported use of gene editing in human embryos was aimed at conferring HIV immunity, criticizing the move as reckless and unnecessary.
The Associated Press reported Sunday that twin girls Lulu and Nana were born after a team led by He Jiankui of the Southern University of Science and Technology in Shenzhen, China, edited their genes when they were days-old embryos. Their father reportedly had HIV, and the procedure wiped out a gene that is usually necessary for the virus to infect cells. The news, first reported by MIT Technology Review, broke before the scientist had published any of his data, and was accompanied by YouTube videos in which He described his work.
Genetics experts immediately criticized the project as premature and said it risked conferring dangerous mutations to the twins.
Adding to that chorus, HIV researchers told BuzzFeed News that such a procedure doesn’t make sense for preventing HIV. Targeting and knocking out a single gene, as He claimed to do, does not offer resistance against all strains of the virus. What’s more...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...